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Abstract
Adaptor protein (AP) complexes regulate clathrin-coated vesicle assembly, protein cargo sorting, and vesicular trafficking
between organelles in eukaryotic cells. Because disruption of the various subunits of the AP complexes is embryonic lethal
in the majority of cases, characterization of their function in vivo is still lacking. Here, we describe the first mutation in the
human AP1S1 gene, encoding the small subunit s1A of the AP-1 complex. This founder splice mutation, which leads to a
premature stop codon, was found in four families with a unique syndrome characterized by mental retardation,
enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratodermia (MEDNIK). To validate the pathogenic effect of
the mutation, we knocked down Ap1s1 expression in zebrafish using selective antisens morpholino oligonucleotides (AMO).
The knockdown phenotype consisted of perturbation in skin formation, reduced pigmentation, and severe motility deficits
due to impaired neural network development. Both neural and skin defects were rescued by co-injection of AMO with wild-
type (WT) human AP1S1 mRNA, but not by co-injecting the truncated form of AP1S1, consistent with a loss-of-function effect
of this mutation. Together, these results confirm AP1S1 as the gene responsible for MEDNIK syndrome and demonstrate a
critical role of AP1S1 in development of the skin and spinal cord.
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Introduction
Protein trafficking between organelles in eukaryotic cells is mainly
mediated by clathrin-coated vesicles and their assembly requires
adaptor protein (AP) complexes [1,2]. The AP complexes also
determine protein cargo selection for transport between the trans-
Golgi network (TGN), endosomes, lysosomes and the plasma
membrane [3,4] and clathrin is important in establishing the
basolateral domain [5]. Four ubiquitous AP complexes (AP 1–4)
have been characterized and each of them is composed of four
subunits. The large subunits (a, c, d or e and b1–4) mediate binding
to the target membrane and clathrin recruitment. The small subunit
s is part of the AP complex core and has been suggested to
contributetothestabilizationofthecomplex,inconjunctionwiththe
medium subunit m, which is primarily involved in protein cargo
sorting [3–6]. Although the molecular understanding of the role of
AP complexes in vesicular transport is progressing rapidly, the
evidence for their role in vivo and in disease is more limited [4–7].
Knockdown or knockout of various AP-complex subunits has been
attempted in different animal models, including the mouse c and m
subunits and C. elegans s subunits of AP-1A [4–7]. However, these
areallembryoniclethal,furtheremphasizingtheimportanceofthese
complexes for appropriate development.
So far, a few but severe genetic disorders caused by mutations in
genes encoding AP complex components have been described in
humans. One of the most studied involves a mutation in the b3A
subunit of AP-3 which underlies the Hermansky–Pudlak syndrome
2 (HPS-2) [8]. This syndrome is characterized by oculocutaneous
albinism, bleeding diathesis with absence of platelet dense bodies
and abnormal depositions of ceroid lipofuscin in various organs.
Mutated AP3B3A is believed to cause abnormal formation of
intracellular vesicles from the trans-Golgi network or late
endosomes, and probably mistrafficking of lysosomal proteins
[7,8]. Recently, three mutations in AP1S2, encoding the s1B
isoform of AP-1, have been associated with X-linked mental
retardation [9]. As AP-1 is associated with synaptophysin and the
vesicular acetylcholine transporter, it was suggested that these
mutations cause abnormal synaptic development and function.
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disease characterized by erythematous lesions and hyperkeratosis
caused by mutations in two epidermally expressed connexin genes,
GJB3 (Cx31) and GJB4 (Cx30.3) [10,11]. Because a significant
proportion of EKV families do not have mutations in GJB3 and
GJB4, additional EKV genes remain to be identified [10]. We
previously described the identification a new locus on chromosome
7q22 for an atypical form of EKV, in families with EKV lesions, as
well as lamellar and erythrodermic ichthyosis (Figure S1) [12]. In
addition to the skin lesions, affected individuals from these families
exhibit severe psychomotor retardation, peripheral neuropathy, and
sensorineural hearing loss, together with elevated very-long-chain
fatty acids and severe congenital diarrhea (Table S1). Given the
similarities with the more recently described CEDNIK syndrome
[13],we used therelated acronymMEDNIK for mental retardation,
enteropathy, deafness, neuropathy, ichthyosis, and keratodermia to
designate this unique syndrome. These MEDNIK families live in a
relatively isolated population descended from a limited number of
ancestors, and the gene responsible for this autosomal recessive
syndromewasmappedbyidentifyingacommonhomozygousregion
[12]. In this study we present a novel splice mutation in human
AP1S1, a ubiquitously-expressed gene encoding the small subunit
s1A of AP-1, in four families with MEDNIK syndrome from the
Quebec population. This founder mutation is predicted to cause the
skipping of exon 3, leading to a premature stop codon at the
beginning of exon 4. To further validate the AP1S1 mutation, we
knocked down native Ap1s1 using antisense morpholino oligonucle-
otides (AMOs) in the developing zebrafish and examined the ability
of wild-type (WT) and mutated human mRNA to rescue the
developmental phenotype. Overall, our results confirm that
mutation of the AP1S1 gene causes MEDNIK syndrome and
suggest a critical implication for the AP1S1 gene in development of
the skin and spinal cord.
Results
Identification of Mutated AP1S1 in Individuals with
MEDNIK
The region harbouring the causative gene for MEDNIK
syndrome, previously named Erythrokeratodermia Variabilis type
3 (EKV3), was recently mapped to a 6.8 Mb segment of
chromosome 7p using a genome-wide single nucleotide polymor-
phisms (SNP) panel in 3 families originating from the Bas-St-
Laurent region in the province of Quebec (Canada), sharing a
common ancestor at the 10th or 11th generation [12]. We
genotyped a fourth pedigree, which enabled us to reduce the
critical region to 5.3 Mb between markers D7S2539 and D7S518
(data not shown). Among the candidate genes mapping to that
interval, GJE1 (encoding a connexin) and CLDN15 (encoding a
claudin) were sequenced but no mutation was found. Recently, a
mutation in a SNARE protein (SNAP29) was associated with
cerebral dysgenesis, neuropathy, ichthyosis and palmoplantar
keratoderma (CEDNIK) [13]. Since clinical manifestations of
CEDNIK show striking similarities to the MEDNIK syndrome
described here, we hypothesized that a mutation in AP1S1,a
functionally related gene mapping to the candidate interval, may
cause the disease. By sequencing the gene, we identified a
mutation in the acceptor splice site (A to G) of exon 3 in all
individuals with MEDNIK (IVS2-2A.G). This splice mutation is
predicted to cause skipping of exon 3, leading to a premature stop
codon at the beginning of exon 4 (Figure 1D). All parents and an
unaffected sibling were heterozygous for this mutation (Figures 1B
and 1C). This mutation was not observed in 180 CEPH controls.
In order to confirm the loss of exon 3, RT-PCR analyses were
performed on mRNA isolated from fibroblasts using primers
located in exons 2 and 4. As expected, a single band was observed
in the controls. In contrast, two bands were detected in the carriers
and patients (Figure 1C). Direct sequencing confirmed that the
lower band corresponded to an mRNA isoform lacking exon 3.
The higher band from the affected individuals corresponded to
another RNA isoform, in which a cryptic splice acceptor site
located 9 bp downstream of the start of the third exon was used.
The resulting in frame protein is thus predicted to lack only three
amino acids (Figure 1D). The full-length AP1S1 mRNA species
was not detected in these individuals. A semi-quantitative RT-
PCR was performed on RNA isolated from mutation carriers and
controls fibroblasts. Whereas heterozygous carriers had wild-type
mRNA levels ranging form 40 to 75% of the expected value, the
relative expression levels of both mutant isoforms was very low in
affected individuals, corresponding to less than 10 % of the
expected amount of RNA (Figure 1C). Western blot analysis of
skin proteins showed faint expression of the AP1S1 protein in
affected individuals, suggesting partial expression of the isoform
lacking three amino acids (Figure S1C). The histological analysis of
the skin revealed an epidermal hyperplasia accompanied by
hypergranulosis and compact hyperkeratosis (Figure S1B).
Ap1s1 Knockdown in Zebrafish: Morphological
Phenotype
To validate whether the AP1S1 mutation found in MEDNIK
patients alters the biological function of this gene, we first knocked
down Ap1s1 in zebrafish by inhibiting mRNA translation using an
AMO [14] targeting its start codon (Figure 1D). The morpholog-
ical deficits of 48 hours post-fertilization (hpf) knocked down (KD)
larvae (n=68/91) are summarized in Figure 2, as the treatment
was embryonic lethal at later stages. The 48 hpf Ap1s1 KD larvae
were well formed but smaller in size compared to WT, and had
reduced pigmentation (Figures 2A and 2D). In addition, the KD
larvae revealed prominent changes in the skin organization which
were most visible in the fins (Figures 2B and 2E). In contrast to the
well-defined, fan-like, ray structure of the WT caudal fin, the fin of
the Ap1s1 KD larvae was disorganized with rounded-up cells
conferring a rough outline. Immature WT larvae did not show
abnormal morphology of the skin and fin, suggesting that this
phenotype is specific to the morpholino treatment rather than a
Author Summary
We describe a novel genetic syndrome that we named
MEDNIK, to designate a disease characterized by mental
retardation, enteropathy, deafness, peripheral neuropathy,
ichthyosis and keratodermia. This syndrome was found in
four French-Canadian families with a common ancestor
and is caused by a mutation in the AP1S1 gene. This gene
encodes a subunit (s1A) of an adaptor protein complex
(AP-1) involved in the organisation and transport of many
other proteins within the cell. By using rapidly developing
zebrafish embryos as a model, we observed that the loss of
this gene resulted in broad defects, including skin
malformation and severe motor deficits due to impairment
of spinal cord development. By expressing the human
AP1S1 gene instead of the zebrafish ap1s1 gene, we found
that the normal human AP1S1 gene could rescue these
developmental deficits but not the human AP1S1 gene
bearing the disease-related mutation. Together, our results
confirm AP1S1 as the gene responsible for MEDNIK
syndrome and demonstrate a critical role of AP1S1 in the
development of the skin and the spinal cord.
A Mutation in AP1S1 Causes MEDNIK
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effect was confirmed by using Ap1s1 Western blotting and
immunolabelling in wholemount larvae. With both methods we
observed a decrease in the intensity of the Ap1s1-specific labeling
in the Ap1s1 KD larvae compared to the WT (Figure 2D, inset,
Figures 2F and 2C). Also, larvae injected with a control AMO (5
mispaired bases) did not show significant differences compared to
the WT (n=26/26, Figure S2D). Finally, in order to mimic the
splice mutation found in individuals with MEDNIK, we designed
a morpholino targeting the Ap1s1 intron 2 acceptor splice site
(Figure 1D, Figure S2G, n=32/58). In this latter experiment, we
found the same abnormal skin and fin morphology as observed by
using AMO targeting the Ap1s1 start codon, although the
phenotype was less penetrant.
To determine if an increase in cell death underlies the skin
phenotype in the KD embryo, we stained these larvae with the
vital dye acridine orange [15]. We did not observe a difference
compared with control (not shown), suggesting that the skin and
fin disorganization was not due to an initial outgrowth followed by
tissue degradation. We further tested whether the skin malforma-
tion was due to a problem in early epidermal patterning by using
immunolabeling for p63, a marker of basal keratinocyte nuclei
[16]. Despite the prominent changes in the size and the shape of
the tail, p63-positive keratinocytes were present both in WT
(Figure 3A) and KD larvae (Figure 3B). To look for a change in the
population of proliferating cells, we performed immunolabelling
with the phosphorylated-histone-H3 (PH3) antibody to visualize
cells undergoing histone modification during mitosis, which did
not reveal any obvious difference between the KD and control
larvae (not illustrated). Similar results were obtained with co-
immunostaining against p63 and PH3, suggesting unaffected
proliferation level of basal keratinocytes population in the KD
larvae (not illustrated). To further investigate whether the
keratinocytes in the KD larvae exhibit specific abnormalities, we
immunolabeled WT and KD larvae for laminin (Figures 3C and
3D) and for cadherin (Figures 3E and 3F). Laminins, in particular
laminin 5, are synthesized by keratinocytes and are their main
anchor to the basement membrane [17], while cadherins are
localized to the keratinocyte cell membrane and are essential in
maintaining cell-cell adhesion [18]. In the WT, laminin was
detected at the outer edges of the fin (Figure 3C) while in the KD
larvae (Figure 3D) the detected laminin appeared diffuse, with an
abnormal localization. Furthermore, in the KD larva, cadherin
immunolabeling was less obvious at the cell membrane of
keratinocytes doubly-labeled with cadherin (green) and p63
(orange) (Figure 3F) In contrast, the localization of cytokeratin, a
major cytoskeletal protein expressed exclusively in epithelial cells
[19,20] seemed to be preserved in KD larvae (Figures 3G and 3H).
Behavioral Deficits and Impaired Spinal Cord
Development in Ap1s1 Knockdown Larvae
At 48 hpf WT larvae normally respond to touch by swimming,
which is characterized by alternating tail movements with a beat
frequency of about 30 Hz (Figure 4A) [21,22]. In contrast, Ap1s1
KD larvae reacted to touch by tail coils (Figure 4F), an embryonic
motility pattern that usually disappears around 24 hpf [21]. Since
the KD larvae exhibited severe motor impairment, we further
investigated the spinal cord neural organization. An anti-
acetylated tubulin staining revealed a reduction in axonal
processes in the spinal cord of Ap1s1 KD larvae (Figure 4G)
compared to the WT (Figure 4B). To quantify the number of
newly born neural cells, wholemount 48 hpf larvae were labeled
using anti-HU, as this RNA binding protein is found in neuronal
cells leaving the mitotic cycle [23]. The number of newly born
Figure 2. Morphological phenotype of Ap1s1 knockdown
zebrafish is rescued by over expression of human AP1S1.
Transmitted light images of 48 hpf Ap1s1 KD larvae show their smaller
size, reduced pigmentation (D) and skin disorganization (E) compared
to the WT (A, B) and the rescued larvae (G,H). Immunofluorescence of
wholemount zebrafish using anti-Ap1s1 antibody showing localization
of Ap1s1 to the plasma membrane (C, polygonal) and to a well defined
perinuclear ring, in both normal (C) and rescued larvae (G), whereas
only a residual and diffuse staining could be observed in KD larvae (F).
Western blot analysis (D, inset) indicates nearly complete knockdown of
Ap1s1 protein (WT=wild-type, KD=knockdown, CTRL=control rat
brain proteins). To normalize the western blot analysis, proteins
extracted from WT, KD and CTRL larvae were incubated with anti-actin.
Scale bars in (A, D, G)=100 mm, (B, C, E, F, H, I-Ciii)=50 mm.
doi:10.1371/journal.pgen.1000296.g002
Figure 1. Identification and characterization of a splice mutation in AP1S1. A) Pedigree of the fourth MEDNIK family from the Kamouraska
region. B) Sequence chromatograms of the intron 2/exon 3 junction of AP1S1 in a normal control (N), a carrier (C) and an affected individual (A) from
family EKV3-02. The filled arrow indicates the mutation (A to G) and the dotted arrow points the cryptic splice site. C) Expression of the AP1S1
isoforms. Relative expression levels of each mRNA species (scaled to 100% of control values on the y-axis) are shown for normal controls (N; n=2)
carriers (C; n=6) and affected individuals (A; n=3). Values were averaged from three independent experiments. 18S RNA was used to normalize the
mRNA quantity. The expression levels from this latter mRNA species could not be distinguished from the wild-type in the carriers in this figure. The
expression levels are indicated as percentage of the control values Inset: RT-PCR showing the different species observed. The upper band (166 bp)
contains the full-length species in both the control (N) and the carrier (C), whereas the lower band (57 bp) corresponds to the species lacking exon 3.
A third mRNA species lacking 9bp, generated by the use of a cryptic splice site, was confirmed by sequencing the upper band (157 bp) of the affected
individual (A). D) Schematic representation of the Human AP1S1 gene. The A.G mutation in the acceptor splice site of exon 3 predicts skipping of
this exon, leading to a premature stop codon. The use of an alternative acceptor splice site within exon 3 results in a mRNA lacking 9 bps coding for
an in frame protein. The location of the two different morpholinos used to knockdown Ap1s1 in zebrafish, targeting either ATG or exon 3 acceptor
splice site, are shown in green.
doi:10.1371/journal.pgen.1000296.g001
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decreased to 51% of control, WT, levels (Figure 4C , n=3, 8169,
p,0.001). We also quantified the progenitor population in the
spinal cord using an anti-PH3, but we did not find a significant
change between Ap1s1 KD and control larvae groups (n=6 each,
not illustrated), nor did we observe significant cell death upon
staining with acridine orange. To study which population of
neurons was specifically affected, we labeled interneurons and
motoneurons by using anti-Pax2, which labels a large subset of
early differentiating interneurons [24] and anti-HB9, a homeobox
gene necessary for motoneuron differentiation [25]. Interestingly,
whereas the number of motoneurons was unchanged (Figures 4D
and 4I; n=3 each, p=0.42), we observed a 46 % reduction in the
number of interneurons in Ap1s1 KD larvae compared to the WT
(Figures 4E and 4J; n=3 each, WT 2861.5, KD 1360, p,0.001).
This behavioral and spinal phenotype was specific to the
morpholino treatment and not just a reflection of general
developmental retardation, as reflected by the sparing of
motoneurons and loss of interneurons, which is not observed
during normal development.
Overexpression of Human mRNA Rescues Ap1s1
Function in AMO Larvae
All larvae co-injected with human wild type human AP1S1
mRNA and Ap1s1 AMO exhibited restoration of the skin
organization, pigmentation (Figures 2G–I), as well as swimming
behavior(n=35/35fish).Conversely,larvaeco-injectedwithhuman
AP1S1-exon3 mRNA and Ap1s1 AMO showed skin and motor
deficits similar to those observed in Ap1s1 KD larvae, suggesting a
loss of function of this truncated form of the protein (Figure S2F,
n=24/24). However, co-injection of the human alternative mutant
AP1S1-9bp mRNA together with the AMO rescued the phenotype
(Figure S2E, n=19/19 fish), suggesting that this protein isoform
lacking 3 amino acids remains functional. Larvae injected with the
mismatch morpholino oligonucleotide were similar both morpho-
logically and behaviorally to the WT (Figure S2D, n=26/26).
Discussion
In this study, we demonstrated that the autosomal recessive
MEDNIK syndrome, described in the population of Quebec, is
caused by a founder mutation in AP1S1. More specifically, we
have shown that the A to G mutation in the acceptor splice site of
exon 3 of AP1S1 (IVS2-2A.G) was associated with skipping of this
exon, leading to a premature stop codon. To our knowledge, this is
the first report of a mutation in the human AP1S1 gene. We also
demonstrated that the IVS2-2A.G mutation produced a loss of
function effect in zebrafish. These findings support the conclusion
that the AP1S1-exon 3 mutation is indeed pathogenic. Our results
are consistent with the recent description of a mutation in
SNAP29, a regulator of vesicle fusion to target membrane, found
in CEDNIK syndrome. Indeed, the CEDNIK syndrome shows
striking similarities to MEDNIK and mutated genes in these two
diseases play a role in vesicular trafficking [13].
Recently, mutations in the s1B subunit of AP-1 (AP1S2) were
identified in patients with X-linked mental retardation [9]. In
contrast to the AP1S1 mutation described here, these individuals
do not exhibit defects in other organs. Presumably, the loss of the
s1B subunit can be compensated in tissues outside of the central
nervous system. Even though the mutations found in AP1S2 are
predicted to cause premature stop codons in exons 2 and 3, it has
not been determined if functional protein products were present in
the affected individuals.
In Vivo Characterization of AP1S1 Function
Little is known about the s subunit role in AP complex formation
and function in vivo. It is suggested that AP1S1 contributes to the AP
complex core stabilization [6,26]. Furthermore, in AP-1 and AP-3,
the s subunit is suggested to interact with ‘‘dileucine-based’’
recognition signal on cargo proteins, in combination with the c or
the d subunit respectively. Therefore, this implicates the s subunit in
protein sorting as well [27]. However, attempts to interfere with
AP1S1 function in vivo were not successful so far, as they resulted in
embryonic lethality. Similar results wereobtained byinterfering with
most of the other subunits of the AP-1 complex, further emphasizing
its importance for appropriate development [4,7]. In this study, we
knocked down Ap1s1 in zebrafish and were able to rescue the
morphological and behavioral phenotypes observed in KDlarvae by
co-injecting WT human AP1S1 mRNA, which further support the
specificity of the Ap1s1 knockdown. The remaining levels of Ap1s1
protein may explain viability in zebrafish, at least for the first
48 hours of development. However, because some of the AP
complexes have overlapping function, compensation by other AP
complexes cannot be excluded [6,28]. Nevertheless, since the Ap1s1
KD larvae exhibit severe deficits, neither residual levels of AP-1A
Figure 3. Ap1s1 knockdown is associated with abnormal
distribution of laminin and cadherin. Despite changes in the size
and shape of the tail, p63-labelled nuclei (orange) of basal keratinocytes
were present in KD larvae. (B). The insets show enlarged views of small
groups of keratinocytes. Immunolabelling for laminin (green) in WT (C)
showed normal distribution of the basement membrane along the fin
fold margin, whereas in the KD larvae the residual laminin labeling was
diffuse and disorganized (D). Compared to WT keratinocytes (E) labeled
with p63 (orange), cadherin (green) is decreased at the cell membrane
of the KD larvae (F). However, the localization of cytokeratin in WT (G)
and in KD larvae (H) appeared similar. Scale bars: 10 mm, Insets in A,
B,=20 mm.
doi:10.1371/journal.pgen.1000296.g003
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appropriate development of many cell types (skin, pigment and
neural).
In this study, we demonstrate for the first time that disruption of
an AP-1 subunit, more specifically the s1A subunit, causes
perturbation in epithelial cell development in vivo. The presence of
p63 immuno positive basal cytokeratinocytes in the KD larva
suggested that knocking down Ap1s1 did not interfere with early
epidermal patterning. The skin phenotype was not accompanied
by an increased cell death or in the level of proliferating basal
keratinocytes. Carney et al. [29] observed an increase in
proliferating basal keratinocytes in zebrafish mutants suffering
from severe epithelial disintegration and suggested that this
phenomenon is a secondary consequence of inflammation and
consequent loss of epithelial integrity. The lack of increased
proliferation in our study could be explained by the presence of
sufficient residual laminin to provide some anchoring for the
keratinocytes, allowing the maintenance of some epithelial
properties. However these residual levels of laminin appeared
insufficient for appropriate basement membrane development.
Interestingly, zebrafish embryos carrying a mutation in the gene
encoding for laminin 5 suffer from severe deficits in fin formation
due to disruption in basement membrane integrity [30]. In Ap1s1
KD larvae, we also found an alteration in the localization of
cadherin in basal keratinocytes, which was not accompanied by
changes in cytokeratin localization, suggesting that this component
of epithelial cells cytoskeleton remain unaffected by AP1S1
dysfunction. Interestingly, the nature of the specific adaptor
complex that recognizes the cadherin dileucine sorting motif is
unknown, although AP-1 is a candidate [18]. Based on these
observations, we suggest that Ap1s1 knockdown resulted in failure
to localize cadherin to the basolateral cell membrane which,
together with an abnormal pattern of expression of laminin 5, lead
to a loss of epidermal layer integrity.
Behavioral Deficits and Abnormal Neural Development
The well-formed 48 hpf Ap1s1 KD larvae showed a severe
behavioral phenotype. Instead of reacting to touch by swimming,
the KD larvae coiled in a motility pattern distinctive of younger
embryos. Consistent with this observation, detailed examination of
the spinal cord revealed an abnormal development. The extent of
axonal processes was diminished and the number of newly born
neurons was reduced to half of the WT levels due mainly to a
decrease in the interneuron population, but not in motoneurons.
Interestingly, as observed in the skin, no change was seen in the
levels of neuronal progenitors in the spinal cord. There is
mounting evidence that AP complexes such as AP-2 and AP-3
are implicated in neural function [31]. For example, mice with
knockout of the AP-3 m3B subunit are susceptible to epileptic
seizures because of deficient GABAergic vesicle formation and
function [32]. Also, mocha, one of the mouse models for
Hermansky-Pudlak syndrome (HPS) in which the d subunit of
AP-3 is mutated, suffer from neurological disorders [33]. The loss
of AP-3 in these mice affected spontaneous and evoked
neurotransmitter release in hippocampal mossy fiber synapses
[34]. AP-2 is implicated in selective endocytosis and recycling of
synaptic vesicles and also of receptors and transporters from the
plasma membrane of nerve terminals [31,35]. For example,
internalization of a-amino-3-hydroxy-5-methylisoxazole-4-propio-
nic acid (AMPA) receptors by binding to AP-2 is essential for N-
methyl-D-aspartic acid (NMDA)-induced long-term-depression in
the hippocampus and therefore to synaptic plasticity [36,37]. In
Figure 4. Abnormal behavioral phenotype and impaired development of spinal neural network of Ap1s1 knockdown zebrafish.
Consecutive images from films illustrating the response to touch in 48 hpf wild type (WT) (A) and Ap1s1 KD larvae (F). The WT larva reacted to touch
by swimming away. In contrast, the Ap1s1 KD larvae exhibit slow and impaired reaction. Immunostaining in wholemount 48 hpf WT (B–E) and Ap1s1
KD larvae (G–J) illustrating the reduced axonal labeling (anti-acetylated tubulin; B and G red, the arrows point to the ventral roots), the reduced
number of newly born cells (anti-HU antibody; red in C and H), and the number of interneurons (anti-Pax2 antibody; E and J green) in the Ap1s1 KD
larvae. In turn, the number of motoneurons (anti-HB9 antibody; D and I, red) was similar both in WT and Ap1s1 KD. Scale bars: 25 mM.
doi:10.1371/journal.pgen.1000296.g004
A Mutation in AP1S1 Causes MEDNIK
PLoS Genetics | www.plosgenetics.org 6 December 2008 | Volume 4 | Issue 12 | e1000296turn, little is known about AP-1 function in neurons, although it
was reported to interact with synaptophysin, one of the most
abundant proteins in synaptic vesicles [38], as well as with
vesicular acetylcholine transporter [39]. Moreover, AP-1 binds to
the ubiquitous microtubule-associated motor protein KIF13A, a
member of a protein family implicated in neuronal transport of
membranous organelles, synaptic vesicles and proteins from the
cell body to the axons and dendrites [40,41]. Mice with mutations
in members of this protein family (KIF1A, KIF1Bb) show reduced
synaptic vesicles in the synaptic terminals and suffer from in
sensory-motor deficits [42]. Also, mutations in KIF1Bb cause
Charcot-Marie-Tooth hereditary peripheral neuropathy type 2A
in humans [42]. It is thus possible that AP1S1, in addition to its
possible implication in synaptic vesicles regulation and formation,
could be implicated in their transport toward the neural processes.
Although not much is known about the precise role of AP-1 in the
developing central nervous system, we show here that the
disruption of the AP-1 function is associated with substantial
perturbation of a subset of spinal interneuron differentiation.
The Zebrafish Ap1s1 Knockdown and Its Contribution to
Understanding of the MEDNIK Syndrome
Ap1s1 KD larvae exhibit abnormal development of neurons and
skin cells, a phenotype that shows similarities to the clinical
manifestations observed in individuals with MEDNIK. Based on
the observation of reduced neurogenesis we have made in zebrafish,
we speculate that MEDNIK syndrome in affected patients is caused
by an impaired development of various neural networks, including
the spinal cord (ataxia and peripheral neuropathy) and possibly the
brain (microcephaly and psychomotor retardation) and inner ear
(sensorineural deafness). We also hypothesize that disruption of
AP1S1 in humans may be associated with more extensive
perturbation of organogenesis. Indeed, growth retardation, digestive
tract malformations and dysfunction (chronic diarrhea), and
elevation of very long chain fatty acid observed in individuals with
MEDNIK syndrome might reflect more widespread perturbation of
vesiculartransportand ofepithelialcelldevelopment.Oneintriguing
question is why the AP1S1-exon 3 mutation is not lethal in
homozygous individuals with MEDNIK. Indeed, overexpression of
human AP1S1-exon3 mRNA failed to rescue the phenotype
observed in Ap1s1 KD larvae, suggesting a loss of function of this
critical protein. However, co-injection of the AP1S1-9bp human
mutant mRNA with AMO, the alternative RNA species detected in
our MEDNIK patients, rescued the phenotype, suggesting that this
alternative splicing results in a functional protein. The expression of
that protein isoform in patients may thus explain their viability. The
fact that the AP1S1-9bp mRNA is expressed at low levels (less than
10 % of normal levels in fibroblasts) could explain why it is not
sufficient to sustain normal development and function and further
highlight the important role of AP1S1 in normal development.
Furthermore, the expression levels of the different AP1S1 isoforms
may vary from one tissue to another, as well as between individuals,
thereby contributing to the variability of the phenotype.
Overall, these observations in zebrafish, in light of previous in
vitro studies [31,34,43–45], suggest that AP1S1 and AP-1 complex
are most likely implicated in appropriate protein sorting and
transport. Interference with these pathways could therefore result
in perturbation of cellular organization and be detrimental for the
development of specific cell subpopulations, as we observed
respectively in the skin and the spinal cord of the Ap1s1 KD
larvae. The results suggest avenues for both basic and clinical
research, in order to better understand the mechanisms underlying
MEDNIK and related neuro-cutaneous syndromes.
Materials and Methods
Patients and Biological Materials
Seventeen individuals from four families including three affected
children were ascertained and examined as described [12].
Genetic material of affected individuals and unaffected siblings
and parents was isolated from blood lymphocytes at Le Service de
Dermatologie du CHRGP de Rivie `re-du-Loup and Le Service de
Ge ´ne ´tique du CHUQ (Ho ˆpital St-Franc ¸ois d’Assise). Fibroblast
cell cultures were obtained from 3 mm punch biopsies from
patients, relatives or healthy controls and were maintained in
Dulbecco’s Modified Eagle’s medium (DMEM) supplemented
with fetal calf serum 10%. The study was approved by the
Institutional Review Board of the Ho ˆpital St-Franc ¸ois d’Assise and
informed consent was obtained from all family members.
DNA Amplification and Mutation Analysis
Coding regions of AP1S1 were amplified by PCR from genomic
DNA (primer sequences are available upon request). Total RNA
was extracted from cultured primary fibroblasts harvested from
skin biopsy samples using standard protocols. cDNA was prepared
using random hexamers and standard procedures, and a fragment
from exon 2 to exon 4 of AP1S1 was amplified with the primers
used for the Taqman exon 3 assay (see below). All DNA templates
were amplified using HotStar Taq polymerase (Qiagen, Valencia,
CA) and standard conditions (95uC for 5 min; 40 cycles of 95uC
for 30 sec, 60uC for 30 sec and 72uC for 30 sec; and 72uC for
10 min.). Amplicons were sequenced in both directions using the
same primers than for PCR.
RT-PCR Analyses
Taqman assay was performed on cDNA (obtained from fibroblast
isolated RNA) using the Taqman kit (Applied Biosystems, Foster
City, CA) and according to the manufacturer’s conditions. For the
exon 2 assay, 300 nM of these PCR primers, AP1S1_exon2F, 59-
gagctcatgcaggttgtcct-39;A P 1 S 1 T a q R ,5 9-AGTTGAAGATGAT-
GTCCAGCTC-39, and 200 nM of the probe, AP1S1TaqP_exon2,
59FAM-CCTGGAGTGGAGGGACCTCAA-TAMRA39,w e r e
used. For the exon 3 assay, 300 nM of these PCR primers,
AP1S1TaqF, 59-TGGAGGGACCTCAAAGTTGT-39 and AP1-
S1TaqR, 59-AGTTGAAGATGATGTCCAGCTC-39,a n d2 0 0
nM of the probe, AP1S1TaqP, 59FAM-CACACTGGAGCT-
GATCCACCGATAC-TAMRA39, were used. All primers were
designed using NM_001283 as the reference sequence. As an
expression control for use in quantification, universal 18S primers
were included in the same reaction mixes. PCR conditions were:
95uC for 10 min, 45 cycles of 30 sec at 95uC, 30 sec at 56uC, and
30 sec at 72uC. Reactions were cycled on the 7900HT Real-time
PCR instrument (Applied Biosystems). Relative expression for each
sample was evaluated by using the difference in the threshold cycle
(DCt ) value to achieve a similar level of fluorescence. 18S relative
expression was used to normalize for the cDNA quantity of each
sample. All values correspond to an average of three independent
experiments.
Cloning of Human AP1S1
We designed primers (AP1S1-59-TAAGCGGATCCATGATG-
CGGTTCATGCTATTATTC, and AP1S1-39-GTAAGCCTC-
GAGTCAGTGGGAAAAGGGGAAAGTGG) to amplify the
complete open reading frame of AP1S1-variant1 from a human
brain cDNA library (Marathon-ready, BD Biosciences Clontech),
using Pfu Polymerase (Stratagene). The same primers were used on
patient’s cDNA to get the mutated alleles, using Advantage 2
Polymerase (Clontech). By using BamHI and XhoI restriction sites
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directionally cloned into pCS2+ vector. All constructs were
completely sequenced to confirm the mutations, as well as to
exclude any other variants that could have been introduced during
the PCR amplification. Capped sense mRNAs were synthesized
from pCS2+ by using the mMESSAGE mMACHINE SP6 kit
(Ambion).
Histology
Skin biopsies were also used to perform histological analysis.
The samples were fixed in formalin 10% and embedded in
paraffin. Sections of aproximately 5 mm were cut by using
cryostat, and stained with haematoxylin and eosin.
Morpholino Knockdown of Ap1s1 in Zebrafish
Experiments were performed on zebrafish (Danio rerio) larvae
raised at 28.5uC according to previously established procedures
[46], and in compliance with Canada Council for Animal Care
and institutional guidelines. To knockdown the function of the
gene encoding for the s1A subunit of AP-1 in zebrafish, which
shares 91% identity with the human AP1S1 protein, an AMO
(Gene Tools) was designed to target the initial codon of zebrafish
Ap1s1 gene (59-ACAGAAGCATAAAGCGCATCATTTC- 39),
which differs in sequence from human AP1S1. In addition, a
second morpholino was designed to target the acceptor splice site
(intron 2) of the zebrafish Ap1s1 gene, 59-GACTAGCATACC-
TACGTAAACACAC-39. All AMO preparation and injection
procedures were according to previously described protocols [13].
The specificity of our AMO was verified by injection of a control,
5 base pairs mismatch morpholino oligonucleotide (59-ACA-
CAAGGATAAACCGCATGATATC- 39) as well as by Western
blotting as will be described below. After establishing the AMO
phenotype (1 mM), rescue experiments were preformed in which
both AMO (1 mM) and human AP1S1 WT or mutated mRNA
(110 ng) were injected.
Western Blot
Skin biopsies were obtained from normal individual, carrier and
patients (lesional and non-lesional skin). The samples were frozen
in liquid nitrogen and homogenized in lysis buffer (RIPA: Tris-
HCl 50 mM, NaCl 150 mM, EDTA pH 8.0, Triton 1%, Sodium
deoxycholate 1%, SDS 0.1%, Protease inhibitors (complete mini,
Roche), Aprotinin 10 mg/ml, Leupeptine 10 mg/ml, phenyl-
methylsulphonyl fluoride (PMSF) 1 mM). The lysates were
centrifuged at 12 000 g for 20 min at 4uC. To quantify gene
knockdown, thirty 48 hpf WT and Ap1s1 KD larvae were
dechorionated and anaesthetized in 0.2% MS-222 (Sigma) and
then homogenized in lysis buffer (150 mM NaCl, 1% IGEPAL
CA-630, 50 mM Tris, pH 8.0, 0.5% sodium deoxycholate, 0.1%
SDS. The lysates were centrifuged 10 min at 2000 g at 4uCi n
complete protease inhibitor cocktail (Roche). After the protein
extraction, western blot protocols were the same for both human
skin samples and zebrafish. The supernatants were removed and
the proteins were quantified using DC protein Assay (BIO-RAD)
with bovine serum albumin (BSA) as a standard. As a primary
antibody, rabbit antisera DE/1 directed against Ap1s1 was used at
a concentration of a 1:5000 (antibody obtained from Dr. Traub)
[47]. Horseradish peroxidase-conjugated donkey anti-rabbit IgG
(1:5000; Jackson Immunoresearch Laboratories Inc.) was used as a
secondary antibody. Visualization was performed by using
Western Lightning Chemiluminescence Reagent Plus (PerkinEl-
mer). Hybridization of the same blot using anti-actin antibody was
used to assess equal loading of the samples (mouse monoclonal
anti-actin 1:5000, Chemicon #MAB1501).
Immunohistochemistry
Briefly, all dechorionated larvae were collected, anesthetized in
0.2% MS-222 (Sigma) and fixed for two hours in 4%
paraformaldehyde (PFA) at room temperature as previously
described [46]. Samples were then washed in phosphate buffered
saline (PBS) before dehydration in 100% methanol and kept at
280uC for later use. For cytokeratin labeling, larvae were stored in
Dent’s fixative at –20uC Primary and secondary antibody
incubations were conducted overnight at 4uC in blocking solution.
Then samples were washed in PBS-Tween and incubated
overnight with Alexa 488 (anti-rabbit) or 568 (anti-mouse)
antibodies (Molecular Probes). After four washouts in PBS-tween,
larvae were mounted on slides in glycerol 90%, for immunoflu-
orescence imaging. Primary antibodies were used at the following
dilutions: rabbit antisera DE/1 directed against Ap1s1 1:200;
monoclonal mouse anti-acetylated tubulin (Sigma) 1:1000; mono-
clonal mouse anti-HB9 (Developmental Studies Hybridoma Bank
81.5C10) 1:200; polyclonal rabbit anti-Pax2 (Covance PRB-276P)
1:100; polyclonal rabbit anti-phosphohistone H3 (Ser10) (Upstate
06 570) 1:100; monoclonal mouse anti-HU (Molecular Probes
A21271) 1:100; rabbit anti-laminin (Sigma L9393) 1:100; rabbit
anti-pan cadherin (Sigma C 3678) 1:400; monoclonal mouse anti-
p63 (Santa Cruz sc-8431) 1:100; monoclonal mouse anti-
cytokeratin type II KS Pan 1-8 (Progen Biotechnik 61006) 1:10.
To verify for cell death in wholemount larva, we stained them
using the vital dye Acridine Orange, as described previously [48].
Imaging
The fluorescent images represent the maximum projection of a
series of 2 mm optical sections obtained in whole mount larva
using a laser confocal microscope (Perkin Elmer Ultraview system
mounted on a LEICA DM LFSA microscope with a 63X oil
objective 1.25 NA) and Metamorph software (Universal Imaging
Corp). Antibody-labeled cells (HU, BH9, PAX2 and PH3) were
counted in equal length spinal cord segments (75 mm) imaged at
the 14th somite and cover the entire spinal cord volume. Statistical
significance between Ap1s1 KD and WT larva groups was verified
using Mann-Whitney rank sum test (Sigmastat). Transmitted light
images were digitized using a digital camera (Axio Cam HRC,
Zeiss) mounted on a dissecting microscope (Stem1 SV 11, Zeiss)
and Axiovision 4.2 software. To document the response to touch
of the 48 hpf larva high-speed video films were digitized (250
frames/sec) using a Photron Fastcam PCI high-speed video
camera mounted on a Zeiss dissection microscope. The captured
films were analyzed off line to determine swim frequency.
Representative images from these films were used to reconstruct
the movements of Ap1s1 KD and WT larvae in Figure 4.
Supporting Information
Figure S1 A) Typical erythrokeratodermia variabilis skin lesion.
B) The histological analysis revealed an epidermal hyperplasia
accompanied by compact hyperkeratosis (CH) and hypergranu-
losis (HG). C) Normalized western blot analysis of skin proteins
indicates faint expression of Ap1s1 in affected individuals (A),
probably because of partial expression of the isoform lacking three
amino acids, compared to mutation carriers KEKV-02-04 (C) and
control (Ctrl).Proteins were extracted from biopsies obtained from
both lesional and non-lesional (*) skin in individual KEKV-01-03.
Found at: doi:10.1371/journal.pgen.1000296.s001 (8.78 MB TIF)
Figure S2 Representative transmitted light images of 48 hours-
old zebrafish larvae illustrating the phenotype under different
experimental conditions. (A) Wild type (WT), non injected larvae.
(B) Knockdown larva, injected with AMO targeting the translation
A Mutation in AP1S1 Causes MEDNIK
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of AMO and human WT mRNA (HmRNA). (D) Larva injected
with a mismatch AMO. (E) Larva rescued by co-injection of AMO
and -9bp Human mRNA. (F) larva co-injected with AMO and -
exon3 HmRNA. (G) Knockdown larva, injected with AMO
targeting the acceptor splice site (intron 2) of Ap1s1.
Found at: doi:10.1371/journal.pgen.1000296.s002 (7.41 MB TIF)
Table S1 Clinical features of affected individuals with MED-
NIK. EKV: erythokeratodermia variabilis; VLCFA: very long
chain fatty acids; NA: not available; mo: month.
Found at: doi:10.1371/journal.pgen.1000296.s003 (0.03 MB
DOC)
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